Symptom-specific Headache Treatment for Brain Injuries
Phase-Based Progress Estimates
University of Calgary, Calgary, Canada
Brain Injuries+11 More
Symptom-specific Headache Treatment - Procedure
You have a chance of qualifying for this trial. We made sure your application will take less than 5 minutes.
What conditions do you have?
What conditions do you have?
Given the rising rates of concussion in youth ages 10-19 and the significant proportion of young people who remain symptomatic for months following concussion, research evaluating the efficacy of multifaceted treatment options following concussion is imperative. Studies examining the efficacy of treatment strategies following concussion in children and adults are surprisingly limited, and most focus on one treatment approach, have small sample sizes, are not randomized controlled trials, and focus on individuals with prolonged recovery (months). There is a need for a multifaceted treatment trial to examine the early implementation of treatment approaches that may reduce prolonged recovery while considering the heterogeneous presentation of symptoms and patient preferences in the sub-acute stage following concussion. Randomized controlled trials that consider a multifaceted transdisciplinary approach to treatment in the early period following concussion are needed to raise the bar regarding evidence-informed management following concussion
Reporting: measured until 3 months from the start of treatment
Closest Location: University of Calgary · Calgary, Canada
2004First Recorded Clinical Trial
4 TrialsResearching Brain Injuries
271 CompletedClinical Trials
Who is running the clinical trial?
University of CalgaryLead Sponsor
692 Previous Clinical Trials
449,535 Total Patients Enrolled
13 Trials studying Brain Injuries
55,656 Patients Enrolled for Brain Injuries
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,216 Previous Clinical Trials
24,391,720 Total Patients Enrolled
16 Trials studying Brain Injuries
10,485 Patients Enrolled for Brain Injuries
Age < 65 · All Participants · 8 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:
You have been diagnosed with a concussion by the study physician.
You have symptoms of dizziness, neck pain, headaches, or sleep disturbance at > one week and < three weeks post injury reported on the PCSS (3-6 on 0-6 Likert scale for at least one of three symptoms).
You are under the age of 19.
You have a Glasgow Coma Scale score of 13-15 if recorded.
You have been diagnosed with a suspected case of infection in the 2 weeks following the injury.
You have a history of migraine or a family history of migraine.
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.